Myriad Genetics (MYGN) Says U.S. Supreme Court to Hear AMP Case
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Goldman Sachs Downgrades Myriad Genetics (MYGN) to Neutral Following SCOTUS Case
December 3, 2012 9:27 AM ESTGoldman Sachs downgraded Myriad Genetics (NASDAQ: MYGN) from Buy to Neutral with a price target of $26.00 (from $34.00) after the Supreme Court of the United States (SCOTUS) agreed to hear the case against the company relating to the patentability of genes.
Given... More
High Court to Review Myriad (MYGN) Patent on Genes
November 30, 2012 3:50 PM ESTShares of generic drug maker Myriad Genetics Inc. (Nasdaq: MYGN) experienced volatility on Friday when news broke that the U.S. high court was going decide whether human genes can be patented.
Myriad Genetics holds patents on two genes linked to... More
Myriad Genetics (MYGN) Resumes Trading, SharesDown 4.5%
November 30, 2012 3:25 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) resumes trading, shares down 4.5 percent on the session.... More
Myriad (MYGN) Falls; Generic Drugmakers to Get High Court Review on Patent Suits
November 30, 2012 3:22 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) shares volatile as generic drugmakers will get U.S. high court review on patent suits.... More
Myriad Genetics (MYGN) trading halted for volatility
November 30, 2012 3:20 PM ESTMyriad Genetics, Inc. (NASDAQ: MYGN) trading halted for volatility.... More
